IMPL Past Earnings image   This IMPL past earnings page last updated 7/1/2022
IMPL Past Earnings
PeriodPast Earnings DateEarnings
Q1 20225/16/2022-1.170
Q4 20213/24/2022-1.070
Q3 202111/15/2021-1.230
Q2 20218/16/2021-0.790
Q1 20216/7/2021-0.540
IMPL Past Revenue
PeriodPast Earnings DateRevenue
Q1 20225/16/20220.00B
Q4 20213/24/20220.00B
Q3 202111/15/20210.09M
Q2 20218/16/2021NA
Q1 20216/7/2021NA
Quotes delayed 20 minutes

Email EnvelopeFree IMPL Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold S&P 500 Stocks
10 Most Overbought S&P 500 Stocks
10 ETFs With Stocks Insiders Are Buying
10 ETFs With Most Upside To Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active S&P Call & Put Options
Impel NeuroPharma (IMPL) is categorized under the Healthcare sector; to help you further research past earnings across stocks, below are some other companies in the same sector:

IMRA Historical Earnings
IMRX Historical Earnings
IMUX Historical Earnings
IMVT Historical Earnings
INAB Historical Earnings
INBX Historical Earnings
INCY Historical Earnings
INDP Historical Earnings
INFI Historical Earnings
INGN Historical Earnings

IMPL Past Earnings Q&A

What was the best and worst IMPL past earnings results?
For Impel NeuroPharma, I'm wondering what the company's very best and worst earnings results have been, on an earnings per share basis?

✔️Accepted answer: The highest IMPL past earnings result in our data set was -0.540/share posted in Q1 2021, while the lowest was in Q3 2021 when IMPL posted -1.230/share.

  Suggested answer: The biggest top line earnings performance — aka revenue — quarter was in Q1 2022 when IMPL reported 0.00B in revenue, while the quarter with the lowest revenue in our data set was Q2 2021 at NA of revenue.

  Suggested answer: There are 5 IMPL past earnings results in our data set.

On this page we presented the IMPL past earnings date information for Impel NeuroPharma. Reviewing that IMPL Past Earnings for the company, we see that the highest past earnings result in our data set was in Q1 2021, when IMPL posted earnings of -0.540/share. Meanwhile the lowest IMPL past earnings result was in Q3 2021, when IMPL posted earnings of -1.230/share. Turning to top line revenue performance, the biggest revenue quarter in our data set was seen in Q1 2022 when IMPL reported 0.00B in revenue, while the smallest revenue quarter was Q2 2021 when IMPL reported NA in revenue.

Any self directed investor doing their due diligence on IMPL or any other given stock can benefit from researching all of the Impel NeuroPharma past earnings — and here, we present each quarter's result all together on one page for easy comparison. Studying this information can help when projecting future earnings, as well as determining whether the past earnings trajectory justifies the current stock value. That's why we bring you PastEarnings.com to make it easy for investors to investigate Impel NeuroPharma past earnings, or the past earnings information for any stock in our coverage universe. And in your continued research we hope you will be sure to check out the further links included for earnings surprises history (beat/miss data) as well as next earnings dates for IMPL. Thanks for visiting, and the next time you need to research IMPL past earnings or those of another stock, we hope you'll think of our site, as your go-to past earnings research resource of choice.

Recommended: Top Ten Hedge Funds Holding EQCN, JUNO Price Target, CABO Dividend Growth Rate.

 

IMPL Past Earnings | www.PastEarnings.com | Copyright © 2020 - 2022, All Rights Reserved

Nothing in PastEarnings.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.